A Novel Whole Tissue Explant Model of Hidradenitis Suppurativa

Phoebe E Leboit,Dhara U Patel,Jarish N Cohen,Madison I Moss,Haley B Naik,Ashley E Yates,Hobart W Harris,Daniel M Klufas,Esther A Kim,Isaac M Neuhaus,Scott L Hansen,Ryan L Kyle,Matt Kelly,Michael D Rosenblum,Margaret M Lowe

DOI: https://doi.org/10.1101/2024.07.19.603617

2024-07-23

Abstract:Hidradenitis Suppurativa (HS) is a relatively common and highly morbid inflammatory skin disease. Due to our relatively limited understanding of HS's pathogenesis, there are currently insufficient treatment options available, and many patients' medical needs are not being met. This is partly due to a scarcity of ex vivo human assays and animal models that accurately recapitulate the disease. To address this deficit, we have developed a whole-tissue explant model of HS to examine its pathogenic mechanisms and the efficacy of potential treatments within intact human tissue. We measured cytokine protein and RNA within whole tissue maintained in an agar-media solution, finding that IL-6 and IL-8 concentrations trended upwards in both HS explants and healthy controls, while IL-17A, IL-1β, and TNF-α exhibited increases in HS tissue alone. We also show that the explants were responsive to treatment with both dexamethasone and IL-2. Not only do our results show that this model effectively delivers treatments throughout the explants, but they also elucidate which cytokines are related to the explant process regardless of tissue state and which are related to HS tissue specifically, laying the groundwork for future implementations of this model.

Immunology

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to develop a brand - new whole - tissue explant model in order to better study the pathological mechanism of Hidradenitis Suppurativa (HS) and evaluate the effectiveness of potential therapeutic drugs. Specifically, the paper aims to:

1. **Solve the deficiencies of existing models**: Currently, there is a lack of in - vitro human models and animal models that can accurately simulate the pathological process of HS, resulting in a limited understanding of the pathogenesis of HS, which in turn affects the research and development of effective treatment methods.

2. **Establish a standardized experimental platform**: By creating an explant model that can maintain the complete human tissue structure, researchers can study disease progression and drug responses in a situation closer to the real pathological environment, while ensuring the consistency and repeatability of experimental conditions.

3. **Reveal the role of specific cytokines**: Through comparative analysis of skin samples from HS patients and healthy control groups, determine which cytokines (such as IL - 6, IL - 8, IL - 1β, TNF - α and IL - 17A, etc.) play a key role in HS lesions, and explore whether the changes of these factors are associated with the disease state.

4. **Test drug efficacy**: Use this model to evaluate the effects of different anti - inflammatory drugs (such as dexamethasone and IL - 2) on HS tissues, and verify whether they can effectively regulate cytokine expression and improve the activity of immune cells.

In summary, the goal of this paper is to fill the current research gaps by constructing a more accurate and practical HS explant model, providing support for in - depth understanding of the pathological characteristics of HS and the development of new treatment strategies.